Kanamycin promotes biofilm viability of MRSA strains showing extremely high resistance to kanamycin
Microbial Pathogenesis · 2024
DOI: 10.1016/j.micpath.2024.106986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2024. Verfasst von Guangchao Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Laboratory Medicine, First Affiliated Hospital of Jinan University, Guangzhou, China; Shunde Hospital of Guangzhou University of C…. Hauptthemen laut MEDLINE: Biofilms, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Clinical Laboratory Medicine, First Affiliated Hospital of Jinan University, Guangzhou, China; Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China.
- Department of Diagnostics, Second Affiliated Hospital of Shantou University Medical College, Shantou, China. Electronic address: tyh27704@163.com.
- Department of Pathology, Qiqihar Medical University, Qiqihar, China.
Zitieren
APA
Yu, G., Huang, T. Y., & Li, Y. (2024). Kanamycin promotes biofilm viability of MRSA strains showing extremely high resistance to kanamycin. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2024.106986
Vancouver
Yu G, Huang TY, Li Y. Kanamycin promotes biofilm viability of MRSA strains showing extremely high resistance to kanamycin. Microbial Pathogenesis. 2024. doi:10.1016/j.micpath.2024.106986
BibTeX
@article{Yu2024,
author = {Yu, Guangchao and Huang, Teng Yi and Li, Yu},
title = {Kanamycin promotes biofilm viability of MRSA strains showing extremely high resistance to kanamycin},
journal = {Microbial Pathogenesis},
year = {2024},
doi = {10.1016/j.micpath.2024.106986}
}
EUVIMED